Olesya Ulanovskaya, Ph.D.
Director, Discovery Biology

Olesya joined Belharra in November 2021 as Director of Discovery Biology supporting early discovery efforts and target validation. Before joining Belharra, Olesya was at the Lundbeck La Jolla Research Center where she served as a team lead applying chemoproteomic approach to early-stage discovery programs in the neuroinflammation space. Prior to Lundbeck, Olesya was at Abide Therapeutics validating novel drug targets and developing covalent serine hydrolase inhibitors for immunology and oncology programs.

Olesya received her Ph.D. degree in Chemical Biology at the University of Chicago and did her post-doctoral research at the Scripps Research Institute.